Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Ann Rheum Dis. 2018 Sep 25;78(3):380–390. doi: 10.1136/annrheumdis-2018-214125

Figure 5.

Figure 5

Immune sera from DR3 mice immunised with SmD peptides and SmD66–80 T-epitope mimic peptides had anti-tissue antibodies (Abs), anti-nuclear antibodies (ANA) and anti-dsDNA Abs. (A) Diverse staining patterns on kidney, salivary gland and skin from B6.Rag1−/−mice at 1/8100 dilutions are seen. (B) They have variable ANA positivity against mouse NIH-3T3 cells at 1/30 SLE.2 Overdilutions. (C) Three of four sera from M2 immunised mice had anti-dsDNA Ab. One of the four immune sera from M9 immunised mice had anti-dsDNA Ab. All immune sera tested were obtained 90 days after the initial immunisation.